Transvenous lead extraction procedures in women based on ESC-EHRA EORP European Lead Extraction ConTRolled ELECTRa registry: is female sex a predictor of complications?


Journal

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
ISSN: 1532-2092
Titre abrégé: Europace
Pays: England
ID NLM: 100883649

Informations de publication

Date de publication:
01 12 2019
Historique:
received: 15 06 2019
accepted: 28 09 2019
pubmed: 31 10 2019
medline: 15 12 2020
entrez: 31 10 2019
Statut: ppublish

Résumé

Female sex is considered an independent risk factor of transvenous leads extraction (TLE) procedure. The aim of the study was to evaluate the effectiveness of TLE in women compared with men. A post hoc analysis of risk factors and effectiveness of TLE in women and men included in the ESC-EHRA EORP ELECTRa registry was conducted. The rate of major complications was 1.96% in women vs. 0.71% in men; P = 0.0025. The number of leads was higher in men (mean 1.89 vs. 1.71; P < 0.0001) with higher number of abandoned leads in women (46.04% vs. 34.82%; P < 0.0001). Risk factors of TLE differed between the sexes, of which the major were: signs and symptoms of venous occlusion [odds ratio (OR) 3.730, confidence interval (CI) 1.401-9.934; P = 0.0084], cumulative leads dwell time (OR 1.044, CI 1.024-1.065; P < 0.001), number of generator replacements (OR 1.029, CI 1.005-1.054; P = 0.0184) in females and the number of leads (OR 6.053, CI 2.422-15.129; P = 0.0001), use of powered sheaths (OR 2.742, CI 1.404-5.355; P = 0.0031), and white blood cell count (OR 1.138, CI 1.069-1.212; P < 0.001) in males. Individual radiological and clinical success of TLE was 96.29% and 98.14% in women compared with 98.03% and 99.21% in men (P = 0.0046 and 0.0098). The efficacy of TLE was lower in females than males, with a higher rate of periprocedural major complications. The reasons for this difference are probably related to disparities in risk factors in women, including more pronounced leads adherence to the walls of the veins and myocardium. Lead management may be key to the effectiveness of TLE in females.

Identifiants

pubmed: 31665280
pii: 5607703
doi: 10.1093/europace/euz277
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1890-1899

Investigateurs

Christopher Peter Gale (CP)
Branko Beleslin (B)
Andrzej Budaj (A)
Ovidiu Chioncel (O)
Nikolaos Dagres (N)
Nicolas Danchin (N)
David Erlinge (D)
Jonathan Emberson (J)
Michael Glikson (M)
Alastair Gray (A)
Meral Kayikcioglu (M)
Aldo Maggioni (A)
Klaudia Vivien Nagy (KV)
Aleksandr Nedoshivin (A)
Anna-Sonia Petronio (AS)
Jolien Roos-Hesselink (J)
Lars Wallentin (L)
Uwe Zeymer (U)
Maria Grazia Bongiorni (MG)
Carina Blomstrom Lundqvist (CB)
Angelo Auricchio (A)
Christian Butter (C)
Nikolaos Dagres (N)
Jean-Claude Deharo (JC)
Christopher A Rinaldi (CA)
Aldo P Maggioni (AP)
Andrzej Kutarski (A)
Charles Kennergren (C)

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.

Auteurs

Anna Polewczyk (A)

Faculty of Medicine and Health Studies, Jan Kochanowski University, Kielce, Poland.
Department of Cardiology, Swietokrzyskie Cardiology Center, 45, Grunwaldzka St., 25-736 Kielce, Poland.

Christopher A Rinaldi (CA)

Department of Cardiology, LLB MBBS, Guy's and St Thomas' Hospitals, London, UK.

Manav Sohal (M)

St. George's University Hospitals NHS Trust, Cardiology Clinical Academic Group, London, UK.

Pier-Giorgio Golzio (PG)

Division of Cardiology, Department of Internal Medicine, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino and University of Turin, Turin, Italy.

Simon Claridge (S)

Department of Cardiology, LLB MBBS, Guy's and St Thomas' Hospitals, London, UK.

Oscar Cano (O)

Unidad de Arritmias, Hospital Universitari i Politècnic La Fe, Valencia, Spain.

Cécile Laroche (C)

EURObservational Research Programme (EORP), ESC, Sophia Antipolis, France.

Charles Kennergren (C)

Department of Cardiothoracic Surgery, Sahlgrenska University Hospital, Goteborg, Sweden.

Jean-Claude Deharo (JC)

Department of Cardiology, CHU La Timone, Service du prof Deharo, Marseille, France.

Andrzej Kutarski (A)

Department of Cardiology, Medical University of Lublin, Lublin, Poland.

Christian Butter (C)

Department of Cardiology, Heart Center Brandenburg in Bernau/Berlin & Brandenburg Medical School, Bernau, Germany.

Carina Blomström-Lundqvist (C)

Department of Medical Science and Cardiology, Uppsala University, Uppsala, Sweden.

Simone L Romano (SL)

Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.

Aldo P Maggioni (AP)

EURObservational Research Programme (EORP), ESC, Sophia Antipolis, France.
ANMCO Research Center, Florence, Italy.

Angelo Auricchio (A)

Division of Cardiology, Fondazione Cardiocentro Ticino, Lugano, Switzerland.

Igor Diemberger (I)

Department of Experimental, Diagnostic and Specialty Medicine, Institute of Cardiology, University of Bologna, Policlinico S.Orsola-Malpighi, Bologna, Italy.

Ennio C L Pisano (ECL)

Cardiology Department, Cardiac Electrophysiology Unit, "Vito Fazzi" Hospital ASL Lecce, Lecce, Italy.

Antonio Rossillo (A)

Cardiology Department, San Bortolo Hospital, Vicenza, Italy.

Karl-Heinz Kuck (KH)

Department of Cardiology, ASKLEPIOS Klinik St. Georg, Hamburg, Germany.

Tamas Forster (T)

2nd Department of Medicine and Cardiology Center, University of Szeged, Szeged, Hungary.

Maria Grazia Bongiorni (MG)

Direttore UO Cardiologia 2 SSN, Azienda Ospedaliero-Universitaria, Pisa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH